INOVIO Pharmaceuticals
NEWS ALERT

INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults

Press Releases

INOVIO Reports Inducement Grant Under Inducement Plan

Posted on October 31, 2025

INOVIO Reports Inducement Grant Under Inducement Plan

Posted on October 31, 2025

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Posted on October 27, 2025

INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025

Posted on October 27, 2025

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Posted on October 23, 2025

INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference

Posted on October 23, 2025

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Posted on October 21, 2025

Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine

Posted on October 21, 2025

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Posted on October 9, 2025

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Posted on October 9, 2025

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.